These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 3285702)

  • 1. A carbamazepine trial in chronic, treatment-refractory schizophrenia.
    Sramek J; Herrera J; Costa J; Heh C; Tran-Johnson T; Simpson G
    Am J Psychiatry; 1988 Jun; 145(6):748-50. PubMed ID: 3285702
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Open clinical trial of carbamazepine in chronic schizophrenic inpatients.
    Wetterling T
    Pharmacopsychiatry; 1987 May; 20(3):127-30. PubMed ID: 3299406
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Carbamazepine as adjunctive treatment in nonepileptic chronic inpatients with EEG temporal lobe abnormalities.
    Neppe VM
    J Clin Psychiatry; 1983 Sep; 44(9):326-31. PubMed ID: 6355069
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A double-blind trial of carbamazepine in negative symptom schizophrenia.
    Nachshoni T; Levin Y; Levy A; Kritz A; Neumann M
    Biol Psychiatry; 1994 Jan; 35(1):22-6. PubMed ID: 7909450
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Comparative efficacy of bromocriptine, carbamazepine and cyproheptadine with neuroleptics in 24 refractory chronic schizophrenic patients].
    Llorca PM; Wolf MA; Lançon C; Bougerol T
    Encephale; 1993; 19(5):565-71. PubMed ID: 8306925
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Valproate management of psychosis in a patient with carbamazepine-induced hyponatremia.
    Karper LP; Seibyl JP; Krystal JH
    J Clin Psychopharmacol; 1992 Apr; 12(2):137-9. PubMed ID: 1573038
    [No Abstract]   [Full Text] [Related]  

  • 7. The use of carbamazepine in the treatment of schizophrenic and schizoaffective psychoses: a review.
    Simhandl C; Meszaros K
    J Psychiatry Neurosci; 1992 Mar; 17(1):1-14. PubMed ID: 1349823
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment of schizophrenia with a vasopressin analogue.
    Iager AC; Kirch DG; Bigelow LB; Karson CN
    Am J Psychiatry; 1986 Mar; 143(3):375-7. PubMed ID: 3513631
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Resistant schizophrenia: what chemotherapy?].
    Vanelle JM
    Ann Med Psychol (Paris); 1993 Apr; 151(4):346-51. PubMed ID: 7904434
    [No Abstract]   [Full Text] [Related]  

  • 10. A critical analysis and discussion of the appropriateness of the schizophrenia consensus remission criteria in clinical pharmaceutical trials.
    Schennach-Wolff R; Möller HJ; Jäger M; Seemüller F; Obermeier M; Messer T; Laux G; Pfeiffer H; Naber D; Schmidt LG; Gaebel W; Klosterkötter J; Heuser I; Maier W; Lemke MR; Rüther E; Klingberg S; Gastpar M; Riedel M
    Pharmacopsychiatry; 2010 Nov; 43(7):245-51. PubMed ID: 20927697
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A preliminary dose-ranging trial of proglumide for the treatment of refractory schizophrenics.
    Hicks PB; Vinogradov S; Riney SJ; Su K; Csernansky JG
    J Clin Psychopharmacol; 1989 Jun; 9(3):209-12. PubMed ID: 2567742
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hydergine for schizophrenia.
    Cohen MR; Pary R; Burns R
    J Clin Psychiatry; 1987 Jan; 48(1):39-40. PubMed ID: 3542983
    [No Abstract]   [Full Text] [Related]  

  • 13. Clozapine for refractory schizophrenia: an open study of 14 patients treated up to 2 years.
    Mattes JA
    J Clin Psychiatry; 1989 Oct; 50(10):389-91. PubMed ID: 2571612
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Carbamazepine in alcohol withdrawal syndromes and schizophrenic psychoses.
    Ballenger JC; Post RM
    Psychopharmacol Bull; 1984; 20(3):572-84. PubMed ID: 6382378
    [No Abstract]   [Full Text] [Related]  

  • 15. Carbamazepine maintenance treatment in outpatient schizophrenics.
    Carpenter WT; Kurz R; Kirkpatrick B; Hanlon TE; Summerfelt AT; Buchanan RW; Waltrip RW; Breier A
    Arch Gen Psychiatry; 1991 Jan; 48(1):69-72. PubMed ID: 1670617
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The use of dopamine agonists in the treatment of schizophrenia.
    Corsini GU; Pitzalis GF; Bernardi F; Bocchetta A; Del Zompo M
    Neuropharmacology; 1981 Dec; 20(12B):1309-13. PubMed ID: 7033816
    [No Abstract]   [Full Text] [Related]  

  • 17. Adjunctive fluoxetine improves global function in chronic schizophrenia.
    Goldman MB; Janecek HM
    J Neuropsychiatry Clin Neurosci; 1990; 2(4):429-31. PubMed ID: 1983785
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Blink rate and blunted affect among chronic schizophrenic patients.
    Kitamura T; Kahn A; Kumar R; Mackintosh JH
    Biol Psychiatry; 1984 Mar; 19(3):429-34. PubMed ID: 6722233
    [No Abstract]   [Full Text] [Related]  

  • 19. A high-dose, double-blind study of ceruletide in the treatment of schizophrenia.
    Mattes JA; Hom W; Rochford JM
    Am J Psychiatry; 1985 Dec; 142(12):1482-4. PubMed ID: 3907376
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pimozide treatment of the negative schizophrenic syndrome: an open trial.
    Feinberg SS; Kay SR; Elijovich LR; Fiszbein A; Opler LA
    J Clin Psychiatry; 1988 Jun; 49(6):235-8. PubMed ID: 3288615
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.